Epstein-Barr virus-specific methylation of human genes in gastric cancer cells
Open Access
- 31 December 2010
- journal article
- Published by Springer Science and Business Media LLC in Infectious Agents and Cancer
- Vol. 5 (1), 27
- https://doi.org/10.1186/1750-9378-5-27
Abstract
Epstein-Barr Virus (EBV) is found in 10% of all gastric adenocarcinomas but its role in tumor development and maintenance remains unclear. The objective of this study was to examine EBV-mediated dysregulation of cellular factors implicated in gastric carcinogenesis. Gene expression patterns were examined in EBV-negative and EBV-positive AGS gastric epithelial cells using a low density microarray, reverse transcription PCR, histochemical stains, and methylation-specific DNA sequencing. Expression of PTGS2 (COX2) was measured in AGS cells and in primary gastric adenocarcinoma tissues. In array studies, nearly half of the 96 human genes tested, representing 15 different cancer-related signal transduction pathways, were dysregulated after EBV infection. Reverse transcription PCR confirmed significant impact on factors having diverse functions such as cell cycle regulation (IGFBP3, CDKN2A, CCND1, HSP70, ID2, ID4), DNA repair (BRCA1, TFF1), cell adhesion (ICAM1), inflammation (COX2), and angiogenesis (HIF1A). Demethylation using 5-aza-2'-deoxycytidine reversed the EBV-mediated dysregulation for all 11 genes listed here. For some promoter sequences, CpG island methylation and demethylation occurred in an EBV-specific pattern as shown by bisulfite DNA sequencing. Immunohistochemistry was less sensitive than was western blot for detecting downregulation of COX2 upon EBV infection. Virus-related dysregulation of COX2 levels in vitro was not recapitulated in vivo among naturally infected gastric cancer tissues. EBV alters human gene expression in ways that could contribute to the unique pathobiology of virus-associated cancer. Furthermore, the frequency and reversability of methylation-related transcriptional alterations suggest that demethylating agents have therapeutic potential for managing EBV-related carcinoma.Keywords
This publication has 98 references indexed in Scilit:
- Epstein‐Barr virus and gastric carcinomaPathology International, 2010
- Cyclooxygenase-2 Polymorphisms, Aspirin Treatment, and Risk for Colorectal Adenoma Recurrence—Data from a Randomized Clinical TrialCancer Epidemiology, Biomarkers & Prevention, 2009
- Meta-analysis Shows That Prevalence of Epstein–Barr Virus-Positive Gastric Cancer Differs Based on Sex and Anatomic LocationGastroenterology, 2009
- Nonsteroidal Antiinflammatory Drugs and Risk of Gastric Adenocarcinoma: The Multiethnic Cohort StudyAmerican Journal of Epidemiology, 2009
- Sensitive and Specific Detection of Early Gastric Cancer with DNA Methylation Analysis of Gastric WashesGastroenterology, 2009
- Methylation-Dependent Binding of the Epstein-Barr Virus BZLF1 Protein to Viral PromotersPLoS Pathogens, 2009
- Promoter methylation-associated loss of ID4expression is a marker of tumour recurrence in human breast cancerBMC Cancer, 2008
- ZEB1 and c-Jun Levels Contribute to the Establishment of Highly Lytic Epstein-Barr Virus Infection in Gastric AGS CellsJournal of Virology, 2007
- DNA methylation-dependent silencing of CST6 in human breast cancer cell linesLaboratory Investigation, 2006
- CpG Islands in vertebrate genomesJournal of Molecular Biology, 1987